Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma

BACKGROUND: Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TIL) in patients with metastatic melanoma has been reported to have a 56% overall response rate with 20% complete responders. To increase the availability of this promising therapy in patients with advanced melanoma, a mini...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarez-Downing, Melissa M, Inchauste, Suzanne M, Dudley, Mark E, White, Donald E, Wunderlich, John R, Rosenberg, Steven A, Kammula, Udai S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408344/
https://www.ncbi.nlm.nih.gov/pubmed/22726267
http://dx.doi.org/10.1186/1477-7819-10-113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408344/
https://www.ncbi.nlm.nih.gov/pubmed/22726267
http://dx.doi.org/10.1186/1477-7819-10-113

Ejemplares similares